Beyond Air, Inc. (NASDAQ:XAIR) shares are rocketing on Tuesday after the company disclosed a deal with XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) to sell 85% of its subsidiary company, NeuroNOS Ltd. The consideration includes 19.9% of XTL's issued shares, $1 million in cash, and milestone-based…
Continue reading...